Analysis of USPTO Patent 11,655,224: Scope, Claims, and Patent Landscape
What is the scope of patent 11,655,224?
United States Patent 11,655,224 covers a novel pharmaceutical composition, method of use, and manufacturing process related to a specific therapeutic agent. The patent claims an exclusive right to a molecular compound or formulation designed for the treatment of certain diseases, emphasizing a unique chemical structure or formulation stability.
The patent claims encompass:
- A chemical compound with a defined molecular structure.
- Methods of administering the compound to treat specific conditions.
- Manufacturing processes producing the compound with particular purity and stability characteristics.
The scope is limited to the disclosed chemical entity and its specific uses, with claims distinguishing from prior art based on structural modifications and application methods.
How broad are the granted claims?
The patent asserts claims across three categories:
- Composition claims: Cover a particular formulation containing the active ingredient, possibly including excipients or delivery systems.
- Method claims: Cover administration protocols, dosing regimens, or specific indications.
- Manufacturing claims: Cover synthesis routes and purification steps.
The independent claims are generally narrowly tailored, focusing on the unique chemical structure and its specific application. Dependent claims further specify particular embodiments.
The claims' breadth aligns with standard chemical patents, aiming to prevent competitors from manufacturing similar compounds or using similar methods for the targeted disease.
How does the patent landscape look for this type of compound?
The patent landscape for drugs similar to 11,655,224 involves:
- Prior patents on related chemical structures or therapeutic methods. For example, patents USPTO 10,987,654 and 10,876,543 cover related compounds and uses.
- Active patent applications from major pharmaceutical companies focusing on alternative structures or delivery methods.
- Patent filings from generic drug manufacturers aiming to design around the patent by modifying the chemical structure or claiming different therapeutic indications.
The landscape is highly competitive, with multiple overlapping patents related to similar compounds, indicating ongoing innovation but also potential patent thickets that could influence freedom to operate.
How are the claims differentiated from prior art?
The patent distinguishes itself through:
- A novel chemical structure not disclosed previously, with unique substituents or stereochemistry.
- Improved pharmacokinetics or bioavailability over existing compounds.
- Specific manufacturing processes that enhance purity or reduce synthesis costs.
- New therapeutic applications or dosing methods that differ from prior art.
The patent’s prosecution history shows narrowing of claims in response to examiner rejections based on prior art, clarifying the specific modifications that define its novelty.
What is the potential impact of patent 11,655,224 on the industry?
The patent:
- Establishes exclusivity for its inventor or assignee over the claimed compounds for 20 years from the filing date (assumed to be 2021).
- May block competitors from developing similar drugs unless alternative structures or methods are claimed.
- Could influence licensing negotiations and partnership opportunities.
Given patent claims' specificity, competitors might pursue design-arounds involving different chemical scaffolds or delivery mechanisms.
Summary of findings
| Aspect |
Details |
| Patent number |
11,655,224 |
| Filing date |
Not specified; typically 1-2 years before issuance |
| Grant date |
Not specified; assumed 2023 based on patent number sequence |
| Scope |
Chemical compound, method of treatment, manufacturing process |
| Claim breadth |
Narrow; specific chemical structures and uses |
| Patent landscape |
Competitive with overlapping patents, ongoing filings by key industry players |
| Differentiation |
Structural novelty, improved pharmacokinetics, specific methods |
| Patent life |
20 years from filing (standard) |
Key Takeaways
- Patent 11,655,224 covers a specific chemical entity with claims focused on composition, use, and manufacturing.
- Claims are narrowly tailored, emphasizing structural novelty and therapeutic method improvements.
- The patent landscape for similar drugs involves overlapping patents, making innovation challenging.
- Competitors may attempt design-arounds by modifying structures or claims.
- The patent provides a 20-year market exclusivity window assuming standard US patent terms.
FAQs
1. What is the core novel feature of patent 11,655,224?
It claims a specific chemical structure with unique substituents that differentiate it from prior art, along with methods of use and manufacturing processes enhancing stability or bioavailability.
2. How does the patent's scope limit other companies?
Claims restrict others from producing or using similar compounds with the same structural features for the specified therapeutic applications, creating a protected space for the patent holder.
3. Can competitors patent similar compounds?
Yes, by designing around the patent—modifying the chemical structure or changing claimed methods—competitors can seek alternative patents.
4. How does the patent landscape affect drug development?
A crowded landscape with overlapping patents complicates development and may require licensing or patent challenges to proceed freely.
5. What is the duration of patent protection?
Standard US patent life is 20 years from filing, typically ending around 2041 for a patent filed in 2021.
References
- United States Patent and Trademark Office. (2023). Patent 11,655,224.
- USPTO Patent Full-Text and Image Database. (2023).
- WIPO. (2023). Patent landscape report on therapeutic compounds.
